Mats Wahlstrom, Director at Coherus BioSciences, Inc. (CHRS), sold 116,554 shares at $34.24 ($4.0M) on 2015-08-14, disclosed to the SEC on 2015-08-18.
Open-market sale of $4.0M CHRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TLSI | BUY | 2024-11-25 | $23K | — | Filing → |
| TLSI | BUY | 2024-11-22 | $47K | — | Filing → |
| CHRS | SELL | 2020-06-19 | $6.9M | — | Filing → |